Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ThisCART19A in B-cell Non-Hodgkin's Lymphoma after autologous CAR-T failure
NCT05349266Phase 1Unknown
- Sponsor
- Zhejiang University
- Start
- Mar 2022
- Primary completion
- Mar 2024
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label trial of thiscart19a in B-cell non-Hodgkin lymphoma (B-NHL), sponsored by Zhejiang University. Status: unknown.
02
Drugs
thiscart19a
03
Conditions
B-cell non-Hodgkin lymphoma (B-NHL)
Beyond the preview
Go deeper on NCT05349266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05349266.